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Background. Cogan’s syndrome is a rare clinical entity whose etiopathology is still unknown, and the treatment strategies are not
clearly defined.Case. A 23-year-oldmale presented with symptoms of headache, peripheral facial palsy, persistent right hearing loss
and bilateral papillitis. Workup excluded all infectious, granulomatous, neoplastic, and immune causes. The diagnosis of atypical
Cogan’s syndrome was established, and the patient was treated with systemic corticosteroids and later on with cyclophosphamide
and methotrexate. There were improvement of visual symptoms and stabilisation of left hearing. Conclusion. Cogan’s syndrome is
a very rare disease with no specific biological tests for the diagnosis. The diagnostic exams are mostly important to exclude other
etiologies. The atypical ocular and audiovestibular manifestations make the diagnosis difficult, delaying the institution of appro-
priate therapy which may result in profound bilateral deafness.
1. Introduction
Cogan’s syndrome (CS) is a very rare disorder of unknown
etiology, most commonly observed in young Caucasian
adults of either gender. It was described in 1945 by Cogan as
an association of nonsyphilitic interstitial keratitis (IK) and
Me´nie`re-like audiovestibular symptoms [1]. Later, in 1980,
Haynes and colleagues suggested that the condition should
include other ocular and audiovestibular symptoms and pro-
posed diagnostic criteria for typical and atypical CS [2].
In the typical form, the ocular involvement is character-
ized by IK, sometimes associated with conjunctivitis, subcon-
junctival haemorrhage, or iritis. On examination, an irregu-
lar, granular, perilimbic corneal infiltrate is observed. Inmost
cases, both eyes are affected during the disease course. In the
atypical form, many ocular lesions have been described,
either isolated or associated with IK, including episcleritis/
scleritis, retinitis, choroiditis, optic neuritis, papillitis, and
central retinal artery occlusion, among others.
The typical ear involvement resembles a picture of
Me´nie`re disease with a rapid onset of vertigo, nausea, vom-
iting, or tinnitus, accompanied with progressive hearing loss,
usually evolving to deafness in 3 months. The hearing loss is
often bilateral from the onset of the disease, but in some
patients it may be unilateral, becoming bilateral later on [3].
In the atypical form, the audiovestibular symptoms are not
characteristic of a Me´nie`re-like disease.
We report a case of an atypical Cogan’s syndrome, the
workup of the diagnosis, and treatment results.
2. Case Report
A 23-year-old male was referred to the emergency roomwith
a 3-month history of peripheral facial palsy, hearing loss,
bilateral optic disc edema, and headaches refractory to pain-
killers in the last few weeks. He had been treated with oral
prednisone for the facial palsy, with improvement of symp-
toms, but when the drug was being tapered, he developed
hearing loss and decreased visual acuity.
At presentation, he had a mild left facial palsy with lago-
phthalmos, a severe impairment of right hearing, and several
papulovesicular lesions on the face and back.
On ophthalmic examination, the best corrected visual
acuity (BCVA) was 20/32 in the right eye and 20/20 in the left
eye. The anterior segment examination was normal, and
intraocular pressure was 13mmHg in both eyes. The fundus
examination revealed mild hyperemia of both optic discs,
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Figure 1: Retinography showing mild hyperemia of both optic discs.
(a) (b)
Figure 2: Audiogram showing complete hearing loss of right ear and no significant alterations of left ear.
with blurred borders, and no signs of vitreous or retinal
inflammation (Figure 1). No other neurologic signs or symp-
toms were found.
From the baseline blood investigation performed, only
the erythrocyte sedimentation rate (ESR) and the C-reactive
protein (CRP) were abnormal (ESR of 27mm/h; CRP of
33,25mg/L). From the infectious and immunological panel,
there was only a positive Weil-Felix reaction.
The cerebral magnetic resonance imaging (MRI) revealed
a cranial multineuritis involving the right II cranial nerve
and III, V, VII, and VIII nerves. All the microbiologic and
serologic tests from the spinal tap were negative and the
opening pressure was normal.
The visual evoked potentials were within normal values.
The audiogram showed a complete hearing loss on the right
side and a normal exam on the left side (Figure 2).
A presumptive diagnosis of Rickettsiosis was considered.
The patient was admitted to the hospital and treated with
oral doxycycline (200mg/day) and corticosteroids for 10 days,
with improvement of the ocular symptoms and facial palsy.
On discharge, the BCVA was 20/20 in both eyes, and there
was residual hyperemia of the right optic disc.
Two weeks later, when the patient was on prednisolone
0,5mg/kg/day, he complained of decreased visual acuity of
the left eye.The BCVAwas 20/20 in the right eye and 20/30 in
the left eye. The ophthalmic examination only revealed mild
edema of the left optic disc.
All the previous workup was repeated and addicionally
a full-body PET scan was performed. The only positive test
was the Weil-Felix reaction, but the IgM and IgG antibodies
for Rickettsia conorii were negative.
It was decided to start a pulse of intravenous methylpred-
nisolone (1 g/day for 3 days) followed by oral prednisolone
1mg/kg/day in a tapering regimen. By the second day of
intravenous steroids, the BCVA of the left eye improved to
20/20 and there was regression of the optic disc edema.
Excluding the infectious, neoplastic, granulomatous, and
autoimmune etiologies and given the response of ocular
manifestations to steroid treatment, we assumed this case as
an atypical Cogan’s syndrome.
Two weeks later, when the patient was on 0,75mg/kg/day
of prednisolone, he complained of decreased left hearing.
The audiogram confirmed a loss of 5–10 db at 4000Hz
(Figure 3). It was decided to start immunosuppression with
intravenous cyclophosphamide 1 g/month for 5 months and
oral methotrexate 20mg/week. There was improvement of
symptoms after the second cyclewith return of the audiogram
to baseline values.
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Figure 3: Evolution of right and left audiograms. There is complete right hearing loss from the beginning. Initially, the left ear audiogram
was normal (a), (b), but the patient started to develop hearing loss at 4000Hz frequency (audiogram (c)). (d) and (e) show recovering of left
hearing after treatment.
Currently, 9 months after the last cycle of cyclophos-
phamide and on methotrexate 15mg/week and prednisolone
5mg/day, the patient is stable with no new visual or hearing
complaints.
3. Discussion
Cogan’s syndrome is a rare disorder.There are no specific tests
for the diagnosis, which is based on the clinical presentation,
medical history, and exclusion of other causes. Due to the
variety of ocular and systemic inflammatory symptoms, there
are numerous differential diagnoses (Table 1).
In this case, a positive Weil-Felix reaction was obtained,
although with no rise of specific antibody titers for Rick-
ettsiae. As all other diagnostic procedures were negative it
was initially assumed as an infectious case. There are several
reports of Rickettsia conorii infection with involvement of
the central nervous system and the posterior segment of
the eye [4–8]. Tsiachris and colleagues reported two cases
of sensorineural hearing loss complicating severe rickettsial
disease [9]. In a recent study [10], Kularatne and Gawaram-
mana showed that the Weil-Felix test suffers from poor
sensitivity and specificity (33% and 46%, resp.). As there
was relapse of the symptoms along with the negativity of
all other investigation, we assumed the case as an atypical
CS. The positive Weil-Felix reaction was interpreted as a
cross-reaction with other autoantibodies or other circulating
autoimmune factors in the picture of an inflammatory state.
No treatment has proven very effective in CS. Corti-
costeroids often have good results on ocular, vascular, and
visceral signs, but the effect on audiovestibular symptoms is
not so effective, especially once deafness is present. Anterior
ocular inflammation, such as IK, anterior uveitis, scleritis,
and episcleritis, usually responds to topical corticosteroids
[11]. Topical or systemic nonsteroidal anti-inflammatory
drugs may be useful in patients with episcleritis and scleritis.
Table 1: Differential diagnosis of Cogan’s syndrome.
Sarcoidosis
Syphilis
Vogt-Koyanagi-Harada syndrome
Rheumatoid arthritis
Whipple’s disease
Systemic lupus erythematosus
Polyarteritis nodosa
Wegener’s granulomatosis
Behc¸et disease
Antiphospholipid antibody syndrome
Ulcerative colitis
Crohn’s disease
Rarely, anterior inflammation may require systemic corticos-
teroid therapy [11, 12]. Posterior ocular involvement requires
treatment with systemic corticosteroids, starting with a dose
of prednisone of 1mg/kg/day and slowly tapering. Failure
to respond within 2-3 weeks of treatment, inability to taper
the corticosteroid to a dose of 10mg/day, or development
of drug induced toxicity are indications for the use of other
immunosuppressive drugs [11, 12].
In this case, as there was relapse of ocular and ear
symptoms when reducing the dose of corticosteroids, there
was the need to use immunosuppressive drugs. Currently
there are no sufficient trials to recommend a specific drug,
although good results have been obtained with methotrexate
[3]. Our option was an approach with intravenous cyclophos-
phamide followed by oral methotrexate to enable tapering
the corticosteroids. There was an improvement of all the
symptoms except the right hearing loss.
When deafness is established it is almost always irre-
versible, although rare exceptions have been reported.Almost
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90% of patients suffer severe hearing loss or total bilateral
deafness, while ocular sequelae are rare [13]. The greatest
long-term ophthalmologic risk in these patients is the devel-
opment of cataracts from the administration of topical and/or
systemic corticosteroids.
In addition to the ocular and audiovestibular symptoms,
some patients may have aortitis or a large- or medium- to
small-sized vessel vasculitis, which also require systemic im-
munosuppressive therapy. Aortitis may develop within weeks
to years of disease onset and has been described in approxi-
mately 10%–12% of patients [14, 15]. It may cause proximal
aorta dilation, aortic valve regurgitation, and thoracoabdom-
inal aortic aneurysms.
In summary, Cogan’s Syndrome is a very rare clinical
entity whose etiopathology is still unknown (infectious and
immunological causes have been evoked). There are no spe-
cific biological tests for the diagnosis, and the investigations
are aimed at excluding other etiologies. The treatment strate-
gies are not clearly defined, and in some cases the atypical
ocular manifestations make the diagnosis difficult delaying
the treatment and resulting in profound bilateral deafness.
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